FREQUENCY OF COMORBID PATHOLOGY INCREASING CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION
Abstract
Purpose of the study: to study the incidence of comorbid pathology that increases the total cardiovascular risk in patients with arterial hypertension (AH). Material and methods: the study was conducted within the framework of the project “Analysis and assessment of factors determining the control of management of patients with arterial hypertension and other cardiovascular diseases in the Kyrgyz Republic”, supported by the Swiss project “Effective management and prevention of non- communicable diseases in Kyrgyzstan”. Medical records of patients registered with a diagnosis of hypertension for 2022 were analyzed. To conduct the study, groups of family doctors (FGPs) were used as the Primary Sampling Unit (PSU). FGPs were selected using probability sampling proportional to population size. Patient medical records - Secondary Sampling Units (SSUs). 40 medical cards were selected from one FGP. 3675 medical records of patients with hypertension throughout the territory of the Kyrgyz Republic were studied. The age of the patients ranged from 19 to 93 years (mean age 62±9 years). The majority of those surveyed were women (2567 respondents - 69.9%), men - 1108 people (30.1%). Research results. Among comorbid diseases, the most common were coronary heart disease (46.5%), angina pectoris (31%), and obstructive sleep apnea syndrome (22.4%). Among men, the most common were coronary heart disease (55.0%), angina (38.8%), and chronic heart failure (26.9%), and among women - coronary heart disease (42.8%), angina ( 27.7%), obstructive sleep apnea syndrome (22.3%). Conclusion. In patients with hypertension, in 85% of cases, comorbid pathology was recorded, which significantly aggravated the patient’s condition and increased the total cardiovascular risk. At the same time, among concomitant diseases, cardiac pathology predominated, primarily various variants of coronary artery disease, the frequency of which prevailed in men compared to women.
Keywords:
arterial hypertension, comorbid pathology, cardiovascular risk, cardiovascular diseases.References
1. Ярмухамедова Д.З., Юсупов О.Ф. Оценка эффективности обучающей программы в условиях поликлиники на приверженность к лечению больных артериальной гипертонией. Вестник КГМА им. И.К. Ахунбаева. 2016;2:23-25.
2. World Health Organization. Cardiovascular Diseases (CVDs) 2017. [Accessed November 2, 2017]. Available from: http://www.who.int/mediacen tre/factsheets/fs317/en/
3. Smith SC, Collins A, Ferrari R, Holmes DR Jr, Logstru, S, McGhi, DV, et al. Our time: a call to save preventable death from cardiovascular disease (heart diseaseand stroke). Circulation. 2012;126(23):2769–2775. https://doi.org/10.1161/CIR.0b013e318267e99f
4. Laslett LJ, Alagona P, Clark BA 3rd, Drozda JP Jr, Saldivar F, Wilson SR, et al. The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American collegeof cardiology. J Am Coll Cardiol. 2012;60(25):S1–S49. https://doi.org/10.1016/j.jacc.2012.11.002
5. Tytel B, Callahan K. Shifting Paradigm: How the BRICS AreReshaping Global Health and Development. New York:Global Health Strategies Initiative; 2012.
6. Mathers C, Stevens G, Mascarenhas M. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: World Health Organization; 2009. Available from: https://iris.who.int/handle/10665/44203
7. World Heart Federation. Cardiovascular disease risk factors. 2015. Available from: http://www.world-heart-federation.org/cardiovascular-health/cardiovascular-disease-risk-factors/ (Accessed 18/05/2015).
8. World Health Organization. Top ten causes of death. 2015. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/ (Accessed17/05/2015).
9. Lackland DT, Weber MA. Global burden of cardiovascular disease and stroke: hypertension at the core. Can J Cardiol. 2015;31(5):569-71. https://doi.org/10.1016/j. cjca.2015.01.009
10. paril S, Acelajado MC, Bakris GL, Berlowitz DR, Cífková R, Dominiczak AF, et al. . Hypertension. Nat Rev Dis Prim (2018) 4:18014. https://doi.org/ 10.1038/nrdp.2018.14
11. Полупанов А.Г., Концевая А.В., Халматов А.Н., Алтымышева А.Т., Суворова Е.И., Романова Т.А. и др. Распространенность артериальной гипертензии среди жителей малых городови сельской местности Кыргызской Республики: этнические особенности (по данным международного исследования “ИНТЕРЭПИД”). Кардиоваскулярная терапия и профилактика. 2013;12(6):4-8. https://doi.org/10.15829/ 17 28-8800-2013-6-4-8
12. Батыралиев Т.А., Махмутходжаев С.А., Кыдыралиева Р.Б., Алтымышева А.Т., Джакипова Р.С., Жорупбекова К.Ш. и др. Распространенность факторов риска неинфекционных заболеваний в Кыргызской Республике (исследование STEPS). Кардиология. 2016;56(11):86-90. https://doi.org/10.18565/ cardio.2016.11.86-90
13. Официальный сайт ЦЭЗ КР. Режим доступа: http://cez.med.kg
14. Централизованный банк данных правовой информации Кыргызской Республики. Национальная программа “Здоровое сердце каждому кыргызстанцу к 2010 году”. Режим доступа: http://cbd.minjust.gov.kg/act/view/ru-ru/6052?cl=ru-ru
15. Централизованный банк данных правовой информации Кыргызской Республики. Государственная программа профилактики и контроля неинфекционных заболеваний в Кыргызской Республике на 2013-2020 годы. Режим доступа: https://cbd.minjust.gov.kg/ 94880/edition/483652/ru
16. Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA) [published correction appears in J Hypertens. 2024 Jan 1;42(1):194]. J Hypertens. 2023;41(12):1874-2071. https://doi.org/10.1097/ HJH.0000000000003480
